Is Anebulo Pharmaceuticals, Inc. (ANEB) a Buy, Sell, or Hold?
OTC : ANEB
Anebulo Pharmaceuticals, Inc.
$0.33 USD
$0.03 (10.0%)
- Volume
- 100
- Average Volume
- 2.54K
- Market Capitalization
- $13.46M
- P/E Ratio
- -1.70
- Dividend Yield
- 0.00%
- Price Target
- $6.00
- Year High
- $3.20
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $16.71
Company Overview
OTC
Richard Anthony Cunningham
Biotechnology
Healthcare
ANEB
3
US
USD
Liquidity Metrics
0.00
16.71
16.71
16.30
0.00
Sales & Valuation
-$
0.00
1.71
-2.30
-0.14
Profitability
-$0.25
-$8.48M
0.00%
0.00%
-74.58%
-84.68%
P/E Metrics
-1.70
-0.04
-0.04
Analyst Price Target & Rating
$6.00
$6.00
$6.00
2/5
4 Analysts
-94.50%
Financial Health Scores
-8.24
1/9
$8.72M
$9.42M
$1.49M
-$7.68M
Key Metrics (TTM)
$3.19M
0.00
-0.43
16.71
-74.58%
-102.66%
-64.73%
-47.73%
0 days
Company Executives
| Name | Title |
|---|---|
| Joseph F. Lawler | Founder & Chairman |
| Daniel V. George | Acting Chief Financial Officer & Secretary |
| Richard Cunningham | Chief Executive Officer & Director |
| Kenneth C. Cundy | Chief Scientific Officer |
Poll Results
No votes yet today — be the first to share your view!
About Anebulo Pharmaceuticals, Inc. (OTC:ANEB) Stock
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. The company’s lead product candidate is the selonabant, a small-molecule antagonist of cannabinoid binding receptor type-1(CB1), which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Lakeway, Texas. ...
Frequently Asked Questions
-
What is the current Anebulo Pharmaceuticals, Inc. (ANEB) stock price?
-
Anebulo Pharmaceuticals, Inc.(OTC:ANEB) stock price is $0.33 in the last trading session. During the trading session, ANEB stock reached the peak price of $3.2 while $0.001 was the lowest point it dropped to. The percentage change in ANEB stock occurred in the recent session was 10.0% while the dollar amount for the price change in ANEB stock was $0.03.
-
ANEB's industry and sector of operation?
-
The OTC listed ANEB is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of ANEB?
-
Joseph F. Lawler | Founder & Chairman
Daniel V. George | Acting Chief Financial Officer & Secretary
Richard Cunningham | Chief Executive Officer & Director
Kenneth C. Cundy | Chief Scientific Officer
| -
How many employees does ANEB have?
-
Number of ANEB employees currently stands at 3. ANEB operates from 1017 Ranch Road 620 South, Lakeway, TX 78734, US.
-
Link for ANEB official website?
-
Official Website of ANEB is: https://www.anebulo.com
-
How do I contact ANEB?
-
ANEB could be contacted at phone #512 598 0931 and can also be accessed through its website. ANEB operates from 1017 Ranch Road 620 South, Lakeway, TX 78734, US.
-
How many shares of ANEB are traded daily?
-
The average number of ANEB shares traded daily for last 3 months was 2.54K.
-
What is the market cap of ANEB currently?
-
The market value of ANEB currently stands at $13.46M with its latest stock price at $0.33